Armenia faces high cervical cancer mortality, experts urge prevention

Around 115 women die from cervical cancer in Armenia each year, according to the Ministry of Health. The country records roughly 270 new cases annually, most diagnosed at late stages, making mortality rates in the region ten times higher than in Western Europe.

The leading cause of cervical cancer is persistent infection with high-risk types of human papillomavirus (HPV), transmitted primarily through sexual contact. Over time, the virus can trigger precancerous changes in cervical cells that may develop into cancer.

Dr Zara Grigoryan stresses that the disease is preventable. Vaccination against HPV, available in Armenia for both girls and boys from the age of 13, is considered the most reliable safeguard, with an effectiveness rate of 99%.

Screening also plays a critical role. Women aged 21 to 65 are advised to undergo cytological testing every three years or HPV testing every five years. Combined screening is also an option. In Armenia, free HPV testing is offered every five years to women aged 30 to 60 at primary healthcare facilities.